EYP-1901 not checked

EyePoint Pharmaceuticals, Inc.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
4 active
8 in total · 3 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
Tested for
Wet Age Related Macular Degeneration (2 trials), wAMD (2 trials), Diabetic Macular Edema (2 trials), DME (2 trials), Diabetic Macular Edema (DME) (2 trials)
Main trialPhase 3
“This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.”In the company’s words, NCT06668064 on ClinicalTrials.gov
Other names
Vorolanib

Other drugs for Wet Age Related Macular Degeneration

All 56 drugs for Wet Age Related Macular Degeneration

Coming up2

Changes1

Last 90 days

Trials8

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 13 Jul 2026 A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56
Phase 3Active, not recruiting 9 Sep 2026 A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56
Phase 3Active, not recruiting Oct 2027 COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Phase 3Active, not recruiting Oct 2027 CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Phase 2Completed 29 Nov 2023 Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)
Phase 2Completed 12 Feb 2024 Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)
Phase 2Completed 24 Oct 2024 Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)
Phase 1Completed 11 May 2022 First in Human Study to Evaluate the Safety and Tolerability of EYP-1901 in Patients With Wet Age Related Macular Degeneration (wAMD)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow EYP-1901

Following is part of Solo: you see every change to EYP-1901 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in